Följ
Miriam Laufer
Miriam Laufer
Verifierad e-postadress på som.umaryland.edu
Titel
Citeras av
Citeras av
År
Return of chloroquine antimalarial efficacy in Malawi
MK Laufer, PC Thesing, ND Eddington, R Masonga, FK Dzinjalamala, ...
New England Journal of Medicine 355 (19), 1959-1966, 2006
5182006
School-age children are a reservoir of malaria infection in Malawi
JA Walldorf, LM Cohee, JE Coalson, A Bauleni, K Nkanaunena, ...
PloS one 10 (7), e0134061, 2015
2362015
Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites
MK Laufer, S Takala-Harrison, FK Dzinjalamala, OC Stine, TE Taylor, ...
The Journal of infectious diseases 202 (5), 801-808, 2010
1812010
Dengue-related deaths in Puerto Rico, 1992–1996: diagnosis and clinical alarm signals
JG Rigau-Pérez, MK Laufer
Clinical infectious diseases 42 (9), 1241-1246, 2006
1582006
Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi
MK Laufer, JJG van Oosterhout, PC Thesing, F Thumba, EE Zijlstra, ...
The Journal of infectious diseases 193 (6), 872-878, 2006
1412006
Antimalarial drug resistance in Africa: key lessons for the future
S Takala‐Harrison, MK Laufer
Annals of the New York Academy of Sciences 1342 (1), 62-67, 2015
1272015
Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data
AEP Frosch, M Venkatesan, MK Laufer
Malaria Journal 10, 1-10, 2011
1212011
Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial
RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, ...
Annals of internal medicine 174 (3), 344-352, 2021
1092021
Return of Widespread Chloroquine-Sensitive Plasmodium falciparum to Malawi
AEP Frosch, MK Laufer, DP Mathanga, S Takala-Harrison, J Skarbinski, ...
The Journal of infectious diseases 210 (7), 1110-1114, 2014
992014
Malaria control in Malawi: current status and directions for the future
DP Mathanga, ED Walker, ML Wilson, D Ali, TE Taylor, MK Laufer
Acta tropica 121 (3), 212-217, 2012
972012
Resistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations
MA Travassos, MK Laufer
Pediatric research 65 (7), 64-70, 2009
962009
Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies
MK Laufer, CV Plowe
Drug Resistance Updates 7 (4-5), 279-288, 2004
962004
Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses
LM Cohee, C Opondo, SE Clarke, KE Halliday, J Cano, AG Shipper, ...
The Lancet Global Health 8 (12), e1499-e1511, 2020
862020
Monitoring and deterring drug-resistant malaria in the era of combination therapy
MK Laufer, AA Djimdé, CV Plowe
Defining and Defeating the Intolerable Burden of Malaria III: Progress and …, 2007
862007
A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV
JJG van Oosterhout, MK Laufer, SM Graham, F Thumba, MA Perez, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 39 (5), 626-631, 2005
862005
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment
LM Cohee, L Kalilani-Phiri, S Boudova, S Joshi, R Mukadam, KB Seydel, ...
Malaria Journal 13, 1-9, 2014
842014
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs
RN Price, G Dorsey, EA Ashley, KI Barnes, JK Baird, U d'Alessandro, ...
Malaria Journal 6, 1-9, 2007
752007
High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross …
JE Coalson, JA Walldorf, LM Cohee, MD Ismail, D Mathanga, RJ Cordy, ...
Malaria journal 15, 1-17, 2016
742016
Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes
L Kalilani-Phiri, PC Thesing, OM Nyirenda, P Mawindo, M Madanitsa, ...
PLoS One 8 (9), e74643, 2013
732013
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential
KA Moser, EF Drábek, A Dwivedi, EM Stucke, J Crabtree, A Dara, Z Shah, ...
genome medicine 12, 1-17, 2020
712020
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20